glutathione in cancer biology and therapy metabolism progression treatment resistance Glutathione-Dependent Pathways in Cancer Cells
Description
BPC 157 therapy counteracted cognitive dysfunction in a novel object recognition test [171], particularly resembling a negative-like symptom [204,205,206,207]
BPC 157 is growing in popularity for the treatment of a variety of conditions
aging processes and how these processes are regulated inside a cell
Vismodegib, as a monotherapy, achieved a 71% ORR in basal cell carcinoma patients [307] and a DCR of 5.3% in gastric cancer patients [308]
